The weight of leptin in immunity

Nature Reviews Immunology

Volumn 4, Issue 5, 2004, Pages 371-379

  La Cava, Antonio ^a   Matarese, Giuseppe ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; INTERLEUKIN 1; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BASAL METABOLIC RATE; BODY FAT; CELL DIFFERENTIATION; FOOD INTAKE; HOMEOSTASIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; METABOLISM; NEUROENDOCRINE SYSTEM; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TH1 CELL; THYMUS;

EID: 2442618838     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1350     Document Type: Review

References (89)

1. Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763-770 (1998).
2. Matarese, G. et al. Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol. 23, 192-187 (2002).
3. Chehab, F., Lim, M. & Lu, R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet. 12, 318-320 (1998).
4. Bennett B. D. et al. A role for leptin and its cognate receptor in hematopolesis. Curr. Biol. 6, 1170-1180 (1996).
5. Sierra-Honigmann, M. R. et al. Biological action of leptin as an angiogenic factor. Science 281, 1683-1686 (1998).
6. Park, H. Y. et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 33, 95-102 (2001).
7. Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-201 (2000).
8. + T-cell responses and is involved in starvation-induced immunosuppression.
9. Sanchez-Margalet, V. et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin. Exp. Immunol. 133, 11-19 (2003).
10. Tumbull, A. V. & Rivier, C. L. Regulation of the hypothelamis-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79 1-71 (1999).
11. Haddad, J. J. et al. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axes. J. Neuroimmunol. 133, 1-19 (2002).
12. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994). This study reports the cloning of the gene encoding leptin in mice and humans.
13. Landman, R. E. et al. Endotoxin stimulates leptin in the human and nonhuman primate. J. Clin. Endocrinol. Metab. 88, 1285-1291 (2003).
14. Grunfeld, C. et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J. Clin. Invest. 97, 2152-2180 (1996).
15. Sarraf, P. et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 185, 171-180 (1997).
16. Fantuzzi, G. & Faggioni, R. Leptin in the regulation of immunity, inflammation, and hematopoieses. J. Leukoc. Biol. 68, 437-446 (2000).
17. Bullo, M., Garcia-Lorda, P., Megias, I. & Salas-Salvado, J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. Res. 11, 525-531 (2003).
18. Amalich, F. et al. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J. Infect. Dis. 180, 908-911 (1999).
19. Orbak, Z., Ertekin, V., Akay, F., Ozkan, B. & Ors, R. Serum leptin levels in neonatal septicemia. J. Pediatr. Endocrinol. Metab. 16, 727-731 (2003).
20. Bornstein, S. R., Preas, H. L., Chrousos, G. P. & Suffredini, A. F. Circulating leptin levels during acute experimental endotoxiemia and antiinflammatory therapy in humans. J. Infect. Dis. 178, 887-890 (1998).
21. Koc, E. et al. Serum leptin levels and their relationship to tumor necrosis factor-α and interleukin-6 in neonatal sepsis. J. Pediatr. Endocrinol. Metab. 16, 1283-1287 (2003).
22. Yarasheski, K. E. et al. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 46, 303-305 (1997).
23. Bruun, J. M. et al. Effects of pro-inflammatory cytokines and chemokines on leptin production in human edipose tissue in vitro. Mol. Cell. Endocrinol. 190, 91-99 (2002).
24. Gerhardt, C. C. et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol. Cell. Endocrinol. 175, 81-92 (2001).
25. Zhang, F. et al. Crystal structure of the obese protein leptin-E100. Nature 387, 206-208 (1997). This paper describes the crystal structure of leptin.
26. Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, Ob-R. Cell 83, 1263-1270 (1995). This study reports the cloning of the gene encoding the leptin receptor.
27. Tartaglia, L. A. The leptin receptor. J. Biol. Chem. 272, 6093-6100 (1997).
28. Banks, A. S., Davis, S. M., Bates, S. H. & Myers, M. G. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275, 14563-14572 (2000).
29. Bjorbaek, C. et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276, 4747-4755 (2001).
30. Sweeney, G. Leptin signaling. Cell Signal. 14, 655-663 (2002).
31. Mancuso, P. et al. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 166, 4018-4024 (2002).
32. Zarkesh-Esfahani, H. et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 167, 4593-4599 (2001).
33. Dixit, V. D., Melenz, M., Taub, D. D. & Parvizi, N. Leptin induces growth hormone secretion from peripheral blood mononuclear cells via a protein kinase C- and nitric oxide-dependent mechanism. Endocrinology 144, 5595-5603 (2003).
34. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B. & Vasson, M. P. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukoc. Biol. 69, 414-418 (2001).
35. Caldefie-Chezet, F., Poulin, A. & Vasson, M. P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 37, 809-814 (2003).
36. Zarkesh-Esfahani, H. et al. Leptin indirectly activates human neutrophils via induction of TNF-α. J. Immunol. 172, 1809-1814 (2004).
37. Siegmund, B., Lear-Kaul, K. C., Faggioni, R. & Fantuzzi, G. Leptin deficiency, not obesity, protects mice from Con A-Induced hepatitis. Eur. J. Immunol. 32, 552-560 (2002).
38. Zhao, Y., Sun, R., You, L., Gao, C., & Tian, Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys Res. Commun. 300, 247-252 (2003).
39. Tian, Z., Sun, R., Wei, H. & Gao, B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys Res. Commun. 298, 297-302 (2002).
40. Howard, J. K. et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104, 1051-1059 (1999). The first study of the effects of leptin on thymic cellularity and function.
41. Lord, G. Matarese, G., Howard, J. K. & Lechler, R. I. The bioenergetics of the immune system. Science 292, 855-856 (2001).
42. Zhang, Y. et al. Peripheral but not central leptin prevents the immunosuppression associated with hypoleptinaemia in rats. J. Endocrinol. 174, 455-461 (2002).
43. Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16, 769-777 (2002).
44. Khaled, A. R. & Durum, S. K. Lymphocide: cytokines and the control of lymphoid homeostasis. Nature Rev. Immunol. 2, 817-830 (2002).
45. Berti, L., & Gammeltoft, S. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol. Cell. Endocrinol. 157, 121-130 (1999).
46. Fujita, Y. et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin. Exp. Immunol. 126, 21-26 (2002).
47. Shimabukuro, M., Wang, M. Y., Zhou, Y. T., Newgard, C. B. & Unger, R. H. Protection against lipoapoptosis of β-cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl Acad. Sci. USA 95, 9558-9561 (1998).
48. Najib, S. & Sanchez-Margalet, W. Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway. Cell. Immunol. 220, 143-149 (2002).
49. + T-cell function and cytokine abnormalities that can be reversed by leptin replacement.
50. Faggioni, R. et al. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-1B. Proc. Natl. Acad. Sci. USA 97, 2367-2372 (2000). This study (together with references 37, 51-53, 56 and 59) shows that leptin-deficient ob/ob mice are resistant to the induction of autoimmunity.
51. Busso, N. et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 188, 875-882 (2002).
52. Matarese G. et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166, 5909-5916 (2001).
53. Sanne, V. et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111, 241-250 (2003). The first report showing that T helper 1 cells can produce leptin and can be found in inflammatory lesions in experimental autoimmune encephalomyelitis.
54. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med. 8, 500-508 (2002).
55. Batocchi, A. P. et al. Leptin as marker of multiple sclerosis activity in patients treated with interferon-β. J. Neuroimmunol. 139, 150-154 (2003).
56. Siegmund, B., Lehr, H. A. & Fantuzzi, G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gatroenterology 122, 2011-2025 (2002).
57. Buyse, M., Sitaraman, S. V., Liu, X., Bado, A. & Merlin, D. Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE. J. Biol. Chem. 277, 28182-28190 (2002).
58. Buyse, M. et al. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J. Clin. Invest. 108, 1483-1494 (2001).
59. Tarzi, R. M., Cook, T. H., Jackson, I., Pusey, C. D. & Lord, G. M. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am. J. Pathol. 164, 385-390 (2004).
60. Matarese, G. et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51, 1356-1361 (2002).
61. Gastke, L. M. Oz, H. S., Frederich, R. C. & McClain, C. J. Anti-TNF-α antibody normalizes serum leptin in IL-2 deficiant mice. J. Am. Coll. Nutr. 22, 415-420 (2003).
62. Matarese, G. et al. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 31, 1324-1332 (2001).
63. Ozata, M., Ozdemir, I. C. & Licinio, J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicates new targets for leptin action, greater central than peripheral resistance to the effect of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3690 (1998).
64. Matarese, G. et al. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J. Clin. Endocrinol. Metab. 85, 2483-2487 (2000).
65. Uygun, A. et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 95, 3584-3589 (2000).
66. Schols, A. M. et al. Plasma leptin is related to pro-inflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, 1220-1226 (1999).
67. Stein, R. B., Lichtenstein, G. R. Rombeau, J. L. Nutrition in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 2, 367-371 (1999).
68. Stenvinkel, P. et al. Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J. Am. Soc. Nephrol. 11, 1303-1309 (2000).
69. Evereklioglu, C. et al. Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity. Br. J. Dermatol. 147, 331-336 (2002).
70. Sera, N. et al. Thyroid hormones influence serum leptin levels in patients with Grave's diseas during suppression of β-adrenergic receptors. Thyroid 10, 641-646 (2000).
71. Mazziotti, G. et al. High leptin levels in women developing post-partum thyroiditis. Clin. Endocrinol. 60, 208-213 (2004)
72. Ahmed, M. L. et al. Elevated leptin levels are associated with excess gains in fat mass in girls, but not in boys, with type 1 diabetes: longitudinal study during adolescence. J. Clin. Endocrinol. Metab. 85, 1188-1193 (2001).
73. Bokarewa, M., Bokarew, D., Hultgren, O. & Tarkowski, A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 62, 952-956 (2003).
74. Anders, H. J., Rihl, M., Heufelder, A. Loch, O. & Schattenkirchner, M. Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48, 745-748 (1999).
75. Chalasani, N. et al. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am. J. Gastroenterol. 96, 2771-2776 (2003).
76. Takabatake, N. et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159, 1215-1219 (1999).
77. Hoppin, A. G. et al. Serum leptin in children and young adults with inflammatory bowel disease. J. Pedaitr. Gastroenterol. Nutr. 25, 500-505 (1998).
78. + lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin. Rheumatol. 18, 394-401 (1999).
79. Kjeldsen-Kragh, J. et al. Controlled trial of fasting and one year vegetarian diet in rheumatoid arthritis. Lancet 338, 899-902 (1991).
80. Payne, A. Nutrition and diet in the clinical management of multiple sclerosis. J. Hum. Nutr. Diet. 14, 349-357 (2001).
81. Beach, R. S., Gershwin, M. E. & Hurley, L. S. Nutritional factors and autoimmunity. III. Zinc deprivation versus restricted food intake in MRL/1 mice - the distincton between interacting dietary influences. J. Immunol. 129, 2686-2692 (1982).
82. Johnson, B. C., Gajjar, A., Kubo, C. & Good, R. A. Calories versus protein in onset of renal disease in NZB × NZW mice. Proc. Natl Acad. Sci. USA 83, 5659-5662 (1986).
83. 1 mice. Proc. Natl Acad. Sci. USA 91, 4402-4406 (1994).
84. Chandrasekar, B. et al. Effects of calorie restriction of transforming growth factor-β1 and proinflammatory cytokines in murine Sjogren's syndrome. Clin. Immunol. Immunopathol. 76, 291-296 (1995).
85. Steinman, L., Conlon, P., Maki R. & Foster, A. The intricate interplay among body weight, stress, and the immune response to friend or foe. J. Clin. Invest. 111, 183-185 (2003).
86. Kuchroo, V. K. & Nicholson, L. B. Fast and feel good? Nature 422, 27-28 (2003).
87. Martin-Romero, C. & Sanchez-Margalet, V. Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell. Immunol. 212, 83-91 (2001).
88. Sanchez-Margalet, V. & Marin-Romero, C. Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cell. Immunol. 211, 30-36 (2001).
89. Van den Brink, G. R. et al. Leptin signaling in human peripheral blood mononuclear cells, on of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol. Cell. Biol. Res. Commun. 4, 144-150 (2000).